Followers | 131 |
Posts | 14996 |
Boards Moderated | 0 |
Alias Born | 06/04/2018 |
Friday, November 15, 2019 7:15:22 PM
Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) ("QIAGEN" or the "Company") announces it has begun a review of potential strategic alternatives after receiving several conditional, non-binding indications of inter...
Read the whole news QGEN - QIAGEN Receives Several Conditional, Non-binding Indications of Interest, and Decides to Enter Into Discussions to Explore Potential Strategic Alternatives
Recent QGEN News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2025 10:00:11 PM
- QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million • Business Wire • 01/16/2025 09:05:00 PM
- QIAGEN gibt Details zum Abschluss des synthetischen Aktienrückkaufs über bis zu rund $300 Mio. bekannt • Business Wire • 01/16/2025 09:05:00 PM
- QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast • Business Wire • 01/15/2025 01:13:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/13/2025 08:46:36 PM
- QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück • Business Wire • 01/12/2025 06:05:00 PM
- QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase • Business Wire • 01/12/2025 06:05:00 PM
- Tiefere Erkenntnisse aus biologischen Proben: QIAGEN erweitert digitales PCR-System QIAcuity um Multiplexing-Funktionen höherer Ordnung • Business Wire • 01/10/2025 06:30:00 AM
- QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples • Business Wire • 01/10/2025 06:30:00 AM
- QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care • Business Wire • 01/09/2025 09:05:00 PM
- QIAGEN erhält U.S.-Zulassung für erstes QIAstat-Dx Mini-Panel für Magen-Darm-Infektionen zur Unterstützung der ganzjährigen ambulanten Versorgung • Business Wire • 01/09/2025 09:05:00 PM
- QIAGEN liefert genomische Inhalte für britische Initiative zur Genomsequenzierung von 100.000 Neugeborenen • Business Wire • 01/07/2025 09:05:00 PM
- QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content • Business Wire • 01/07/2025 09:05:00 PM
- QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data • Business Wire • 12/12/2024 09:05:00 PM
- QIAGEN führt KI-Erweiterung für Ingenuity Pathway Analysis zur automatisierten Interpretation biologischer Daten ein • Business Wire • 12/12/2024 09:05:00 PM
- QIAGEN erreicht Meilenstein: Über 1.000 platzierte EZ2 Connect-Systeme zur Probenvorbereitung treiben Laborautomatisierung voran • Business Wire • 12/05/2024 09:05:00 PM
- QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation • Business Wire • 12/05/2024 09:05:00 PM
- QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing • Business Wire • 11/28/2024 11:00:00 AM
- QIAGEN stärkt QIAstat-Dx mit neuem Standort in Barcelona zur Wachstumsbeschleunigung bei Tests für Infektionskrankheiten und Präzisionsmedizin • Business Wire • 11/28/2024 11:00:00 AM
- QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis • GlobeNewswire Inc. • 11/27/2024 09:05:00 PM
- QIAGEN collaborates with McGill University to advance microbiome research • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/07/2024 04:46:20 PM
- QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook • GlobeNewswire Inc. • 11/06/2024 09:05:00 PM
- QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics • GlobeNewswire Inc. • 11/04/2024 06:30:00 AM
- QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment • GlobeNewswire Inc. • 10/29/2024 06:30:00 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM